Congrats to those buried on this one seeing a little coming back. No idea if this deal is actually good in terms of the vascular market or not, gut feeling tells me something is up as I don’t know how WP could swing a favourable deal with the company in such dire straights. But I have nothing to go on besides my gut at this point.
What I’d really like to see if the spending come under control. If we no longer need a sales force, then they should go. Where is manufacturing happening now? (Haven’t had tome to read all release yet). Finally, what about those BoD salaries? Any chance of a correction on those. Should really consider lowering until company is truly solvent.
22m is nothing when the overheads were so high, and why this hasn’t rebounded as hard as some would have liked.
all the best.
- Forums
- ASX - By Stock
- AVR
- Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-115
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M |
Open | High | Low | Value | Volume |
$19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 475 | $18.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.91 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 475 | 18.700 |
1 | 10 | 18.630 |
2 | 1027 | 18.610 |
1 | 1000 | 18.600 |
2 | 475 | 18.580 |
Price($) | Vol. | No. |
---|---|---|
18.910 | 100 | 1 |
19.500 | 21 | 1 |
20.000 | 1800 | 4 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online